AMD is reported to be negotiating to buy Xilinx, and a deal could come as soon as next week. If the two companies agree, the deal would likely be worth approximately US$30 billion, according to The Wall Street Journal.
The value of AMD shares has soared of late, which means it should be able to much more easily swing a deal, and pay largely in stock. The WSJ reported that AMD’s stock grew 89% this year, and the company now has a valuation over US$100 billion. Xilinx, meanwhile, has had to contend with the vicissitudes of President Donald Trump’s trade war with China; it tried and failed to secure a dispensation to keep supplying Huawei.
AMD buying Xilinx would be the second mega-merger announced this year, following Nvidia’s announcement that it intends to buy Arm Holdings for US$40 billion.
The AMD-Xilinx combination is much more reminiscent of Intel’s purchase of Altera in 2015 for approximately US$16.7 billion, however. It would be another instance of a leading provider of CPUs buying a specialist in FPGAs, and for similar reasons, to gain control of a complementary chip technology important in data centers in general, and with artificial intelligence (AI) workloads specifically. FPGAs are often used for AI acceleration.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI